Biomedical Engineering Reference
In-Depth Information
64. Escors D, Breckpot K (2010) Lentiviral vec-
tors in gene therapy: their current status and
future potential. Arch Immunol Ther Exp
(Warsz) 58:107-119
65. Yang L, Bailey L, Baltimore D et al (2006)
Targeting lentiviral vectors to specifi c cell
types in vivo. Proc Natl Acad Sci U S A
103:11479-11484
66. Lei Y, Joo KI, Wang P (2009) Engineering
fusogenic molecules to achieve targeted trans-
duction of enveloped lentiviral vectors. J Biol
Eng 3:8
67. Morizono K, Xie Y, Ringpis GE et al (2005)
Lentiviral vector retargeting to P-glycoprotein
on metastatic melanoma through intravenous
injection. Nat Med 11:346-352
68. Anliker B, Abel T, Kneissl S et al (2011)
Specifi c gene transfer to neurons, endothelial
cells and hematopoietic progenitors with len-
tiviral vectors. Nat Methods 7:929-935
69. Funke S, Maisner A, Muhlebach MD et al
(2008) Targeted cell entry of lentiviral vec-
tors. Mol Ther 16:1427-1436
70. Funke S, Schneider IC, Glaser S et al (2009)
Pseudotyping lentiviral vectors with the wild-
type measles virus glycoproteins improves
titer and selectivity. Gene Ther 16:700-705
71. Morizono K, Bristol G, Xie YM et al (2001)
Antibody-directed targeting of retroviral vectors
via cell surface antigens. J Virol 75:8016-8020
72. Ohno K, Sawai K, Iijima Y et al (1997) Cell-
specifi c targeting of Sindbis virus vectors dis-
playing IgG-binding domains of protein
A. Nat Biotechnol 15:763-767
73. Lei Y, Joo KI, Zarzar J et al (2010) Targeting
lentiviral vector to specifi c cell types through
surface displayed single chain antibody and
fusogenic molecule. Virol J 7:35
74. Croyle MA, Yu QC, Wilson JM (2000)
Development of a rapid method for the
PEGylation of adenoviruses with enhanced
transduction and improved stability under
harsh storage conditions. Hum Gene Ther
11:1713-1722
75. Kreppel F, Kochanek S (2008) Modifi cation
of adenovirus gene transfer vectors with syn-
thetic polymers: a scientifi c review and techni-
cal guide. Mol Ther 16:16-29
76. Sailaja G, HogenEsch H, North A et al
(2002) Encapsulation of recombinant adeno-
virus into alginate microspheres circumvents
vector-specifi c immune response. Gene Ther
9:1722-1729
77. Boerger AL, Snitkovsky S, Young JA (1999)
Retroviral vectors preloaded with a viral
receptor-ligand bridge protein are targeted to
specifi c cell types. Proc Natl Acad Sci U S A
96:9867-9872
78. Roux P, Jeanteur P, Piechaczyk M (1989) A
versatile and potentially general approach to
the targeting of specifi c cell types by retrovi-
ruses: application to the infection of human
cells by means of major histocompatibility
complex class I and class II antigens by mouse
ecotropic murine leukemia virus-derived
viruses. Proc Natl Acad Sci U S A 86:
9079-9083
79. Benitez JA, Segovia J (2003) Gene therapy
targeting in the central nervous system. Curr
Gene Ther 3:127-145
80. Kugler S, Lingor P, Scholl U et al (2003)
Differential transgene expression in brain cells
in vivo and in vitro from AAV-2 vectors with
small transcriptional control units. Virology
311:89-95
81. Nettelbeck DM (2008) Cellular genetic tools
to control oncolytic adenoviruses for viro-
therapy of cancer. J Mol Med (Berl)
86:363-377
82. Glover CP, Bienemann AS, Heywood DJ et al
(2002) Adenoviral-mediated, high-level, cell-
specifi c transgene expression: a SYN1-WPRE
cassette mediates increased transgene expres-
sion with no loss of neuron specifi city. Mol
Ther 5:509-516
83. Nathanson JL, Yanagawa Y, Obata K et al
(2009) Preferential labeling of inhibitory and
excitatory cortical neurons by endogenous
tropism of adeno-associated virus and lentivi-
rus vectors. Neuroscience 161:441-450
84. Peel AL, Zolotukhin S, Schrimsher GW et al
(1997) Effi cient transduction of green fl uo-
rescent protein in spinal cord neurons
using adeno-associated virus vectors contain-
ing cell type-specifi c promoters. Gene Ther
4:16-24
85. Klein RL, Meyer EM, Peel AL et al (1998)
Neuron-specifi c transduction in the rat septo-
hippocampal or nigrostriatal pathway by
recombinant adeno-associated virus vectors.
Exp Neurol 150:183-194
86. Zhang GR, Wang X, Yang T et al (2000) A
tyrosine hydroxylase-neurofi lament chimeric
promoter enhances long-term expression in
rat forebrain neurons from helper virus-free
HSV-1 vectors. Brain Res Mol Brain Res
84:17-31
87. Loftus SK, Erickson RP, Walkley SU et al
(2002) Rescue of neurodegeneration in
Niemann-Pick C mice by a prion-promoter-
driven Npc1 cDNA transgene. Hum Mol
Genet 11:3107-3114
88. Sirin O, Park F (2003) Regulating gene
expression using self-inactivating lentiviral
vectors containing the mifepristone-inducible
system. Gene 323:67-77
Search WWH ::
Custom Search